Skip to main content

Larry Blandford, PharmD—Column Editor

Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model
Pharma Insights
09/18/2020
The Centers for Medicare & Medicaid Services (CMS) announced its third annual evaluation report of the Oncology Care Model (OCM) in July 2020, covering performance periods 1-3 activities and results. In March...
The Centers for Medicare & Medicaid Services (CMS) announced its third annual evaluation report of the Oncology Care Model (OCM) in July 2020, covering performance periods 1-3 activities and results. In March...
The...
09/18/2020
Journal of Clinical Pathways
Journeying Through the Past, Present, and Future of Medicare Part D
Pharma Insights
06/17/2020
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...
This...
06/17/2020
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
03/16/2020
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways
Where Will Health Care Take Us in the 2020s?
Pharma Insights
02/18/2020
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade—not an easy task. Looking back at commentary and predictions...
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade—not an easy task. Looking back at commentary and predictions...
As we...
02/18/2020
Journal of Clinical Pathways
Pharma Insights
08/19/2019
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value...
08/19/2019
Journal of Clinical Pathways
Pharma Insights
06/18/2019
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education: so-called hub services have become ubiquitous...
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education: so-called hub services have become ubiquitous...
What...
06/18/2019
Journal of Clinical Pathways
Pharma Insights
05/15/2019
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr...
05/15/2019
Journal of Clinical Pathways
Pharma Insights
12/13/2018
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
...
12/13/2018
Journal of Clinical Pathways
Pharma Insights
09/13/2018
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the...
09/13/2018
Journal of Clinical Pathways
Pharma Insights
04/17/2018
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
...
04/17/2018
Journal of Clinical Pathways